Tag Archive for: life sciences

Sofinnova Partners unveils Sofinnova.AI: A cutting-edge artificial intelligence platform set to transform its life sciences investment practice

Combination of real time scientific databases with proprietary data will enable venture capital firm to enhance deal origination and portfolio growth through data-driven insights and strengthened entrepreneurial partnerships   PARIS, France – December 5, 2023 –  Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the […]

Novo Holdings advances antimicrobial resistance strategy with acquisition of Paratek Pharmaceuticals

Paratek’s successful commercialisation platform to advance novel therapies developed organically and through acquisitions Paratek adds ‘final-mile’ capabilities to AMR efforts COPENHAGEN, September 21, 2023 – With the closing of the acquisition of Paratek Pharmaceuticals, Inc. (“Paratek”), a commercial-stage biopharmaceutical company focused on the development and commercialisation of novel therapies for life-threatening diseases and other public health […]

Brace yourself for the busiest week in biopharma!

More than hangover-busting aspirin will be in order at the biopharma industry’s biggest week in London.  The capital will host a gruelling conference double header, beginning with the LSX Inv€$tival Showcase on Monday 13th November, followed by the Jefferies London Healthcare Conference on Tuesday 14th November.  With investors and biopharma business leaders descending on the […]

The ‘must-attend’ Healthcare conferences Autumn / Winter 2023

It is quite astonishing just how quick time flies – so let’s look ahead to the top events coming up for Autumn / Winter 2023/24… Now really is the time to be organising your calendar for the latter half of the year, so don’t miss the early-bird discounts, and secure your travel and accommodation whilst […]

Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure

US study seeking to confirm strong efficacy data reported in RED DESERT and SAHARA Initial data expected in Q4 2023 Ghent, Belgium – 10 July 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that the first patient has […]